```html

Asherman's Syndrome: A Complete Guide

What is Asherman's Syndrome?

Asherman's syndrome, also called intrauterine adhesions (IUA), is a condition in which scar tissue forms inside the uterine cavity. The scar tissue (fibrous bands) can partially or completely obliterate the uterine cavity and the cervical canal, leading to menstrual abnormalities, infertility, recurrent pregnancy loss, and chronic pelvic discomfort.

The syndrome was first described by British gynecologist Frank Asherman in the 1940s. It is relatively uncommon, affecting roughly 1–2 % of women who undergo uterine surgery, but the true prevalence may be higher because many cases are mild and go undiagnosed.<sup>1</sup>

Common Causes

Intra‑uterine adhesions develop when the basal layer of the endometrium (the functional lining) is damaged and heals with fibrous tissue instead of normal endometrial cells. The most frequent precipitating events include:

• ​Post‑partum curettage (D&C) after a complicated delivery.
• ​Uterine surgery – myomectomy, hysteroscopic polypectomy, or endometrial ablation.
• ​Repeated hysteroscopic procedures or multiple dilatation & curettage (D&C) sessions.
• ​Infection – severe endometritis or pelvic inflammatory disease (PID) can damage the endometrial lining.
• ​Radiation therapy to the pelvis (e.g., for cervical or endometrial cancer).
• ​Severe postpartum hemorrhage requiring aggressive uterine evacuation.
• ​Uterine trauma from obstetric instrumentation (e.g., forceps, vacuum extraction).
• ​Congenital uterine anomalies that predispose to scarring after minor injury.
• ​Intra‑uterine infection with tuberculosis (more common in endemic regions).
• ​Use of high‑dose estrogen‑blocking agents after surgery, which may impede normal healing.

Associated Symptoms

Not all women experience symptoms, especially when adhesions are minimal. When they do appear, the most common clinical features include:

• Menstrual changes – hypomenorrhea (light periods), amenorrhea (absence of periods), or complete menstrual cessation.
• Infertility – difficulty conceiving despite regular intercourse and normal ovulation.
• Recurrent pregnancy loss – early miscarriage or repeated implantation failure.
• Pain – pelvic or lower‑abdominal discomfort, especially during menstruation (dysmenorrhea) or intercourse (dyspareunia).
• Abnormal uterine bleeding – spotting between periods or after intercourse.
• Failed assisted reproductive techniques – low success rates with IVF or IUI.

When to See a Doctor

Prompt evaluation is important because early detection improves the chances of restoring a normal uterine cavity. Seek medical advice if you notice any of the following:

• Missing periods for three consecutive months after a previously regular cycle.
• Sudden, unexplained decrease in menstrual flow.
• Difficulty becoming pregnant after trying for 12 months (or 6 months if you are over 35).
• Repeated early pregnancy loss without an obvious cause.
• Persistent pelvic or lower‑back pain that does not improve with typical OTC pain relievers.
• History of recent uterine surgery, D&C, or severe postpartum hemorrhage combined with any of the above signs.

Diagnosis

Diagnosis relies on a combination of a thorough history, physical examination, and imaging or endoscopic evaluation.

1. Medical History & Physical Exam

The clinician will ask about prior uterine procedures, infections, pregnancy history, menstrual patterns, and any infertility work‑up already performed. A pelvic exam may reveal a shortened uterine cavity or an irregular cervix, but most findings are subtle.

2. Imaging Studies

• Transvaginal Ultrasound (TVUS) – First‑line, non‑invasive test. May show a thin or irregular endometrium, fluid collections, or a “pseudopolyp.” Sensitivity is modest for mild adhesions.
• Sonohysterography (SHG) – Saline infusion into the uterine cavity during ultrasound improves visualization of contour irregularities and can identify small adhesions.
• Magnetic Resonance Imaging (MRI) – Reserved for complex cases or when other pelvic pathology is suspected.

3. Direct Visualization – Hysteroscopy

The gold‑standard diagnostic tool. A thin hysteroscope is inserted through the cervix, allowing the surgeon to view, grade, and often treat adhesions in the same session. Adhesions are graded (e.g., American Fertility Society classification) based on extent and depth, guiding management.

4. Laboratory Tests (Adjunctive)

• Baseline hormone profile (FSH, LH, estradiol) if infertility is a concern.
• TB testing (PPD or IGRA) for patients from endemic areas.

Treatment Options

Management aims to restore a functional uterine cavity, preserve fertility, and prevent recurrence. Treatment can be divided into surgical, medical, and supportive measures.

1. Surgical Management

• Hysteroscopic adhesiolysis – The primary treatment. Under direct vision, the surgeon uses scissors, a resectoscope, or laser to cut fibrous bands. The procedure is usually performed under general or spinal anesthesia.
• Adjunctive measures to reduce re‑adhesion:
  • Intra‑uterine balloon catheters left for 7–14 days post‑operatively.
  • Estrogen therapy (e.g., 2–6 mg oral estradiol daily) for 30–60 days to promote regrowth of healthy endometrium.
  • Use of hyaluronic acid gel or anti‑adhesion barriers (e.g., Seprafilm) placed at the end of surgery.
• Repeat hysteroscopy – Recommended 4–6 weeks after the first surgery for patients with moderate–severe adhesions to assess for recurrence and perform additional adhesiolysis if needed.

2. Medical Therapy

• Estrogen–Progesterone “priming” – High‑dose estrogen followed by cyclic progesterone helps regenerate the endometrium after adhesiolysis.
• Gonadotropin‑releasing hormone (GnRH) agonists – Occasionally used pre‑operatively to reduce uterine bleeding and improve visualization.
• Antibiotics – Prophylactic coverage (e.g., doxycycline 100 mg BID for 7 days) is standard after hysteroscopic surgery to prevent infection.

3. Assisted Reproductive Techniques (ART)

For women whose fertility does not return spontaneously after surgery, IVF or IUI can be pursued once the uterine cavity is deemed adequate. Successful pregnancy rates after hysteroscopic repair range from 30–70 % depending on adhesion severity.<sup>2</sup>

4. Home & Lifestyle Support

• Maintain a balanced diet rich in iron, vitamin C, and folate to support endometrial healing.
• Avoid smoking and excessive alcohol, which impair uterine blood flow.
• Stay hydrated; adequate fluid intake can help reduce menstrual cramping.
• Follow post‑operative instructions precisely—avoid heavy lifting or vigorous pelvic exercise for 2 weeks.

Prevention Tips

Because many cases arise after a uterine procedure, preventive strategies focus on minimizing trauma and ensuring optimal healing.

• Limit D&C procedures – Whenever possible, use medical management (e.g., misoprostol) for retained products of conception instead of surgical curettage.
• Use hysteroscopic techniques (e.g., hysteroscopic polypectomy) rather than blind curettage; they are more precise and cause less endometrial damage.
• Administer prophylactic estrogen after any uterine surgery that breaches the basal layer, especially in women desiring future fertility.
• Prompt treatment of uterine infections – Early antibiotics for endometritis reduce scar formation.
• Educate patients about the signs of abnormal bleeding after procedures, encouraging early follow‑up.
• Consider alternative uterine‑sparing treatments for fibroids or polyps, such as MRI‑guided focused ultrasound or medication (e.g., GnRH antagonists).
• Maintain a healthy weight – Obesity is linked to higher rates of postoperative adhesion formation.

Emergency Warning Signs

Key Takeaways

Asherman's syndrome is a treatable cause of menstrual irregularities and infertility. Early recognition—particularly after uterine instrumentation—allows for minimally invasive hysteroscopic repair and a higher chance of restoring normal reproductive function. While surgery is the cornerstone of therapy, adjunctive estrogen therapy, anti‑adhesion barriers, and careful follow‑up are essential to prevent recurrence. Patients should remain vigilant for abnormal bleeding or severe pain after any uterine procedure and seek prompt medical attention when warning signs arise.

For further reading, consult reputable sources such as the Mayo Clinic, CDC, NIH, WHO, and the Cleveland Clinic.

```